RAMSAY SANTE : date of approval of the final consolidated financial statements for the year ending June 2021


You May Also Like

Albireo Provides First Quarter 2018 Business Update

 First patient enrolled in Phase 3 trial of IBAT inhibitor A4250 in PFIC   Elobixibat ...

Cue Biopharma to Host Investor Business Update Call and Webcast

Update on progress of selective immune modulation platformCAMBRIDGE, Mass., May 10, 2018 (GLOBE NEWSWIRE) ...